Concepedia

Andrew C. Kruegel

AC

Statistics

Publications

16

Citations

1.5K

H-Index

14

Active since

2009

Affiliations

Columbia University(Current)

New York Psychoanalytic Society and Institute

New York State Psychiatric Institute

Rutgers, The State University of New Jersey

Memorial Sloan Kettering Cancer Center

Andrew C. Kruegel is an author at Columbia University specializing in pharmacology, medicine, and opioid pharmacology.

ORCID

Publications per year

2009–2024

16

Publications

16

Synthetic and Receptor Signaling Explorations of the <i>Mitragyna</i> Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators

Andrew C. Kruegel, Madalee M. Gassaway, Abhijeet Kapoor et al. · Journal of the American Chemical Society · 2016 · 320 citations · Full text

, , +17

The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor

Benjamin A. Samuels, Katherine M. Nautiyal, Andrew C. Kruegel et al. · Neuropsychopharmacology · 2017 · 277 citations · Full text

, , +16

7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects

Andrew C. Kruegel, Rajendra Uprety, Steven G. Grinnell et al. · ACS Central Science · 2019 · 220 citations · Full text

, , +12

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist

Madalee M. Gassaway, Andrew C. Kruegel, Jonathan A. Javitch et al. · Translational Psychiatry · 2014 · 194 citations · Full text

, , +17

Kratom policy: The challenge of balancing therapeutic potential with public safety

Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer et al. · International Journal of Drug Policy · 2019 · 106 citations · Full text

, , +12

1–5 of 16